SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043068
Filing Date
2023-11-29
Accepted
2023-11-29 16:30:34
Documents
13
Period of Report
2023-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46915
  Complete submission text file 0001493152-23-043068.txt   270790

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20231122.xsd EX-101.SCH 3967
3 XBRL DEFINITION FILE bfri-20231122_def.xml EX-101.DEF 26984
4 XBRL LABEL FILE bfri-20231122_lab.xml EX-101.LAB 37236
5 XBRL PRESENTATION FILE bfri-20231122_pre.xml EX-101.PRE 25604
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6124
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 231452636
SIC: 2834 Pharmaceutical Preparations